ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,808Medicare Part D Prescriptions Filled, Including Refills

Rank: 303 out of 890

$376K Total Retail Price of All Prescriptions

Rank: 350 out of 890

620 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 620 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 6,558 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
METFORMIN HCL 378 313 1 6
LEVOTHYROXINE SODIUM 297 289 2 2
METOPROLOL TARTRATE 227 191 3 15
GLIMEPIRIDE 223 182 4 27
LISINOPRIL 220 181 5 4
PRAVASTATIN SODIUM 205 172 6 10
FUROSEMIDE 177 158 7 7
AMLODIPINE BESYLATE 176 152 8 1
SIMVASTATIN 157 147 9 5
CITALOPRAM HBR 153 125 10 20
HYDROCODONE-ACETAMINOPHEN 145 99 S3 11 3
ZOLPIDEM TARTRATE 120 93 12 19
CARVEDILOL 114 102 13 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 106 80 14 21
HYDROCHLOROTHIAZIDE 105 95 15 9
METOPROLOL SUCCINATE 92 88 16 17
CEFDINIR 92 67 16 191
OMEPRAZOLE 92 91 16 8
ATORVASTATIN CALCIUM 91 85 19 13
SERTRALINE HCL 90 75 20 26
MELOXICAM 85 59 21 18
SYNTHROID 82 60 22 53
JANUVIA 77 77 23 59
GABAPENTIN 75 57 24 12
TRAMADOL HCL 67 59 25 16
POTASSIUM CHLORIDE 65 53 26 11
DILTIAZEM 24HR ER 62 55 27 149
LOSARTAN POTASSIUM 62 46 27 29
METHYLPREDNISOLONE 61 52 29 109
AMITRIPTYLINE HCL 59 47 R 30 43
ALLOPURINOL 58 51 31 31
ALENDRONATE SODIUM 58 58 31 38
CIPROFLOXACIN HCL 57 47 33 58
ATENOLOL 56 53 34 23
CRESTOR 55 55 35 25
WARFARIN SODIUM 54 41 36 24
KLOR-CON M20 51 47 37 72
GEMFIBROZIL 50 40 38 103
TRIAMTERENE-HCTZ 50 35 38 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 29, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.